NCT03969693View on ClinicalTrials.gov

Lymphoma Patients Undergoing Mediastinal Radiotherapy in the Era of Modern Chemoradiation

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Mediastinal LymphomaHodgkin LymphomaNon Hodgkin Lymphoma
Interventions
RADIATION

Standard treatment protocol with combined chemoradiation

As for consolidative RT used in patients with early-stage Hodgkin lymphoma, the RT field must essentially include the mediastinum.

Trial Locations (1)

333

Chang Gung Memorial Hospital, Taoyuan District

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT03969693 - Lymphoma Patients Undergoing Mediastinal Radiotherapy in the Era of Modern Chemoradiation | Biotech Hunter | Biotech Hunter